Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis
Marcus M. Mücke, Amelie Mayer, Johanna Kessel, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 9, pp. 1916-1924
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Scott W. Biggins, P. Angeli, Guadalupe García‐Tsao, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 1014-1048
Closed Access | Times Cited: 514
Microbiome therapeutics for hepatic encephalopathy
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1452-1464
Open Access | Times Cited: 56
Asia–Pacific association for study of liver guidelines on management of ascites in liver disease
Virendra Singh, Arka De, Rohit Mehtani, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 792-826
Open Access | Times Cited: 23
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S3, pp. 493-523
Open Access | Times Cited: 23
Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study
Peter Hunyady, Lea Streller, Darius F. Rüther, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e179-e187
Open Access | Times Cited: 31
Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
Marcus M. Mücke, María Hernández‐Tejero, Wen Gu, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 877-888
Open Access | Times Cited: 6
Advances in Gut Microbiota of Viral Hepatitis Cirrhosis
Yixuan Wang, Calvin Q. Pan, Huichun Xing
BioMed Research International (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 46
Comparison of Bacterial Infections in Patients With Cirrhosis Between Hospitals With and Without Liver Transplant in Catalonia
Clàudia Torras, Juan Bañares, Aina Martí‐Carretero, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis
Marcus M. Mücke, Victoria T. Mücke, Christiana Graf, et al.
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 8, pp. e00223-e00223
Open Access | Times Cited: 35
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration
Bryan D. Badal, Scott Silvey, Lyuba Dragilev, et al.
Hepatology (2023) Vol. 77, Iss. 6, pp. 2030-2040
Closed Access | Times Cited: 12
Antibiotics in decompensated liver disease - who, when and for how long?
Frederic Haedge, Tony Bruns
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?
Simona Juncu, Horia Minea, A Lungu, et al.
Life (2025) Vol. 15, Iss. 4, pp. 586-586
Open Access
Impact of Quinolone Prophylaxis on Spontaneous Bacterial Peritonitis and Mortality in Cirrhosis Patients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Ajay Malvi, Nipun Verma, Mahalaqua Nazli Khatib, et al.
JGH Open (2025) Vol. 9, Iss. 4
Open Access
Emergency medicine updates: Spontaneous bacterial peritonitis
Brit Long, Michael Gottlieb
The American Journal of Emergency Medicine (2023) Vol. 70, pp. 84-89
Open Access | Times Cited: 7
Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program
Zhanjie Li, Dan Zhu, Xiaoju Ma, et al.
Antimicrobial Resistance and Infection Control (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Bacterial Infections in Acute-on-chronic Liver Failure: Epidemiology, Diagnosis, Pathogenesis, and Management
Zhaoyu Xu, Xiuding Zhang, Jian‐Zhang Chen, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Yuzhu Dong, Dan Sun, Yan Wang, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
New molecular entities and structure–activity relationships of drugs designed by the natural product derivatization method from 2010 to 2018
Qingxin Cui, Ruibin Bian, Feng‐Bo Xu, et al.
Studies in natural products chemistry (2021), pp. 371-415
Closed Access | Times Cited: 12
Alfapump®implantable device in management of refractory ascites: An update
Delphine Weil, Vincent Di Martino, Guido Stirnimann, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 7, pp. 1344-1356
Open Access | Times Cited: 6
Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens
Zhanjie Li, Ying Zhang, Weihong Zhang, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 5945-5952
Open Access | Times Cited: 6
Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review
Πέτρος Ιωάννου, Stamatis Karakonstantis, Jeroen Schouten, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 3, pp. 362-370
Open Access | Times Cited: 8
Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany
Annika Hillert, Marie Schultalbers, Tammo Lambert Tergast, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci
Lina M. Schulte, Jacob Nattermann, Christian P. Strassburg, et al.
Liver International (2023) Vol. 43, Iss. 9, pp. 2039-2041
Open Access | Times Cited: 2
Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding
Victoria T. Mücke, Kai‐Henrik Peiffer, Johanna Kessel, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268638-e0268638
Open Access | Times Cited: 4
A New Calcium(II)-Based Substitute for Enrofloxacin with Improved Medicinal Potential
Hou-Tian Yan, Ruixue Liu, Qi-Zhen Yang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 249-249
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top